Home/Filings/4/0000905148-24-002566
4//SEC Filing

Soleymannezhad Ali 4

Accession 0000905148-24-002566

CIK 0001287098other

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 4:34 PM ET

Size

7.3 KB

Accession

0000905148-24-002566

Insider Transaction Report

Form 4
Period: 2024-09-16
Soleymannezhad Ali
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2024-09-16+10,40026,025 total
  • Award

    Employee Stock Option (right to buy)

    2024-09-16+20,80020,800 total
    Exercise: $4.12Exp: 2034-09-15Common Stock (20,800 underlying)
Footnotes (2)
  • [F1]These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Twenty-five percent (25%) of the RSUs shall vest on September 16, 2025, and the remainder shall vest in three (3) equal annual installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
  • [F2]Twenty-five percent (25%) of the shares underlying this option shall vest on September 16, 2025, and the remainder shall vest in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Documents

1 file

Issuer

MAXCYTE, INC.

CIK 0001287098

Entity typeother

Related Parties

1
  • filerCIK 0002037336

Filing Metadata

Form type
4
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 4:34 PM ET
Size
7.3 KB